HP and metastatic melanoma: Thus, sequential therapies with Hp inhibitors is not indicated, while more therapeutic options can be evaluated for immunotherapy and targeted sequential therapies (i.e., targeted therapy and sequential immunotherapy in metastatic melanoma).